Population Versus Practice-based Interventions to Increase Immunizations
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01296906|
Recruitment Status : Completed
First Posted : February 16, 2011
Last Update Posted : June 21, 2013
One of the nation's major health priorities, as outlined in Healthy People 2010, is to increase the proportion of children aged 19 to 35 months who have received all universally recommended vaccines. This study will compare two interventions for increasing immunization rates in this age group, one using well-studied primary care practice-based methods and the other using innovative technologies to increase immunization rates at the population-level. Results of this study will provide data that will be relevant nationally in guiding future investment of resources to increase up-to-date rates in young children prior to school entry.
Hypothesis: Population-based approaches will be more effective than practice-based interventions at increasing immunizations among 19-35 month olds.
|Condition or disease||Intervention/treatment||Phase|
|Health Services Research Comparative Effectiveness Immunization||Behavioral: Recall conducted by private practices Behavioral: Recall conducted centrally by local health department||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||31567 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Health Services Research|
|Official Title:||Population Versus Practice-based Interventions to Increase Immunizations|
|Study Start Date :||May 2010|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||September 2012|
Experimental: Population-based Reminder/Recall
Recall is performed centrally by public health departments for all children in need of immunizations in a geographic area.
Behavioral: Recall conducted centrally by local health department
A centralized recall of children 19-35 months will be conducted through local health departments. CIIS will identify a cohort of 19-35 month olds with an who are in need of an immunization and will coordinate up to 3 mailers to children who are not current for recommended immunizations.
Experimental: Practice-based Reminder/Recall
Reminder/Recall is performed by individual private practices for their patients who appear in need of immunizations.
Behavioral: Recall conducted by private practices
All practices in these counties will receive training on practice-based R/R using the Colorado Immunization Information System (CIIS or immunization registry). Practices will receive a recommended schedule for conducting recall in 19-35 month children and educational materials to use within their practices to promote compliance with the infant vaccination schedule. Individual practices will make their own decisions about the extent to which they follow the recommendations and implement recall within their practice. Although the study team will not provide them with any additional interventions, we will track any other interventions they independently do (websites, newsletters, telephone informational systems) in order to assess the effect of these additional interventions.
- Evaluate effectiveness of population-based reminder/recall methods versus practice-based reminder/recall methods in 14 Colorado counties (rural and urban) [ Time Frame: 6 months post-intervention (December 2010) ]The primary outcome measures will be: 1) change in up-to-date rates from baseline levels 6 months after the intervention (T-1) for 19-35 month olds in population-based compared to practice-based intervention counties and 2) percent of children who were not up-to-date prior to recall (T-0) who received any additional new vaccine in each type of intervention county.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01296906
|United States, Colorado|
|Denver, Colorado, United States|
|Principal Investigator:||Allison Kempe, MD, MPH||University of Colorado, Denver|